Substantially optically pure S-oxybutynin, or a pharmaceutically acceptable salt thereof, is administered as a treatment for asthma. Such treatment is provided while reducing the adverse effects associated with the administration of racemic oxybutynin.

The invention relates to a method for forming output signals of an interference current monitor or of a state monitor of an electrical rail vehicle with current being drawn from a power grid, and optionally a current also being delivered back into said power grid, via a current collector. In the case of a state monitor, not only interference currents but also further fault states are identified and signaled. The method steps include detection by measurement and digitization of the vehicle curren...

The invention concerns a composition comprising a microemulsion forming system by contact with a hydrophilic phase brought, after ingestion, by the physiological fluid, said microemulsion forming system comprising: at least an active principle; a lipophilic phase; a surfactant (TA); a co-surfactant (CoTA). The invention is characterized in that said composition further comprises an inert polymeric matrix which cannot be ionised at physiological pH, dispersed in the microemulsion forming system b...

A method and composition are disclosed utilizing the pure (S,R) isomer of formoterol, which is a bronchodilator with reduced adverse effects. (S,R)-Formoterol may be conveniently and safely formulated for aerosol administration.

An apparatus and its use for chemical synthesis is disclosed. In one embodiment, the apparatus comprises a solid support input and a plurality of reagent inputs, wherein each input is connectable to a main fluid pathway via a respective switchable valve. The apparatus further comprises a reaction chamber that is fluidly connectable to the main fluid pathway by a respective switchable valve downstream of the inputs, and that includes an outlet downstream of a barrier that prevents passage of soli...

Wound dressings and coated implantable medical devices include a styrene sulfonate polymer. Organic and inorganic therapeutic agents may be incorporated in the copolymer. Inorganic therapeutic agents are oligodynamic metals, especially silver.

Methods and compositions are disclosed utilizing hydroxyomeprazole for the treatment of ulcers in humans. Hydroxyomeprazole exhibits a lessened liability toward drug-drug interactions than omeprazole and a more predictable dosing regimen than omeprazole. Hydroxyomeprazole is also useful for the treatment of gastroesophageal reflux and other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome.

A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, having a low incidence of the development of tolerance and having increased duration of action.

A pharmaceutical composition comprising a cyclosporin solid-state microemulsion is disclosed. In a preferred embodiment, the composition comprises a cyclosporin microemulsion dispersed in an enteric carrier. The composition does not dissolve in external phases such as artificial gastric fluid, but dissolves rapidly in artificial intestinal fluid, whereby it releases the cyclosporin microemulsion, providing rapid delivery of cyclosporin. The composition effectively maintains a therapeutic blood c...

Furniture pieces, including tables, shelf units, chairs and combinations of these, are provided, wherein parts of the furniture, such as the back, sides, and shelves, represent parts of the body of a figure, such that the furniture piece is a three-dimensional representation of the figure. An object holder and organizer includes a first side member, a second side member, a horizontally-extending member for supporting the objects, attached to the first side member and the second side member, and ...